The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
CRF1receptor signaling pathways are involved in stress‐related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome
Open accessAbstract
The characterization of corticotropin releasing factor (CRF) and, more recently, the discovery of additional CRF‐related ligands, urocortin 1, urocortin 2 and urocortin 3, the cloning of two distinct CRF receptor subtypes, 1 (CRF 1) and 2 (CRF 2), and the development of selective CRF receptor antagonists provided new insight to unravel the mechanisms of stress. Activation of brain CRF 1 receptor signaling pathways is implicated in stress‐related endocrine response and the development of anxiety‐like behaviors. Compelling evidence in rodents showed also that both central and peripheral injection of CRF and urocortin 1 mimic acute stress‐induced colonic response (stimulation of motility, transit, defecation, mucus and watery secretion, increased ionic permeability and occurrence of diarrhea) in rodents. Central CRF enhances colorectal distention‐induced visceral pain in rats. Peripheral CRF reduced pain threshold to colonic distention and increased colonic motility in humans. Nonselective CRF 1/CRF 2 antagonists and selective CRF 1 antagonists inhibit exogenous (central or peripheral) CRF‐ and acute stress‐induced activation of colonic myenteric neurons, stimulation of colonic motor function and visceral hyperalgesia while selective CRF 2 antagonists have no effect. None of the CRF antagonists influence basal or postprandial colonic function in nonstressed animals. These findings implicate CRF 1 receptors in stress‐related stimulation of colonic function and hypersensitivity to colorectal distention. Targeting CRF 1‐dependent pathways may have potential benefit against stress or anxiety‐/depression‐related functional bowel disorders. British Journal of Pharmacology(2004)141, 1321–1330. doi:10.1038/sj.bjp.0705760
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965 · cited 1×
“Corticotropin releasing factor (CRF, also known as cortico- tropin releasing hormone) was characterized by Vale et al. in 1981 as a novel 41-amino-acid hypothalamic peptide that stimulates the synthesis and release of ACTH and b-endorphin from the pituitary (Vale et al., 1981).”
BackgroundThe role of corticotropin-releasing factor in depression and anxiety disorders
Arborelius, L., Owens, M., Plotsky, P., & Nemeroff, C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600001 · Cited by 1,378
Regulation of the Hypothalamic-Pituitary-Adrenal Axis by Cytokines: Actions and Mechanisms of Action
TURNBULL, A. V., & RIVIER, C. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.1 · Cited by 1,297
Lewis, K., Li, C., Perrin, M. H., Blount, A., Kunitake, K., Donaldson, C., Vaughan, J., Reyes, T. M., Gulyas, J., Fischer, W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121165198 · Cited by 925
Reyes, T. M., Lewis, K., Perrin, M. H., Kunitake, K. S., Vaughan, J., Arias, C. A., Hogenesch, J. B., Gulyas, J., Rivier, J., Vale, W. W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051626398 · Cited by 887
Dunlop, S. P., Jenkins, D., Neal, K. R., & Spiller, R. C. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.028 · Cited by 583
V. Stress and irritable bowel syndrome
Mayer, E. A., Naliboff, B. D., Chang, L., & Coutinho, S. V. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.4.g519 · Cited by 413 · cited 1×
“In healthy humans, stress increased colonic sensation during short-term colonic distention (Ford et al., 1995; Mayer et al., 2001).”
BackgroundLevel of chronic life stress predicts clinical outcome in irritable bowel syndrome
Bennett, E. J., Tennant, C. C., Piesse, C., Badcock, C.-A., & Kellow, J. E. (1998) · Gut · doi:10.1136/gut.43.2.256 · Cited by 405
Francis, D. D., Caldji, C., Champagne, F., Plotsky, P. M., & Meaney, M. J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00237-1 · Cited by 380 · cited 1×
“…that peripheral administration of a selective CRF1 receptor antagonist, NBI-35965, prevented WAS-induced hyperalgesia to colorectal distention in adult rats exposed to neonatal maternal separation that associated with higher brain CRF levels in adults (Cratty et al., 1995; Francis et al., 1999).”
BackgroundSagami, Y., Shimada, Y., Tayama, J., Nomura, T., Satake, M., Endo, Y., Shoji, T., Karahashi, K., Hongo, M., & Fukudo, S. (2004) · Gut · doi:10.1136/gut.2003.018911 · Cited by 291
Cited by
Enck, P., Aziz, Q., Barbara, G., Farmer, A. D., Fukudo, S., Mayer, E. A., Niesler, B., Quigley, E. M. M., Rajilić-Stojanović, M., Schemann, M., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.14 · Cited by 997
Anxiety disorders and comorbid medical illness
Roy-Byrne, P. P., Davidson, K. W., Kessler, R. C., Asmundson, G. J. G., Goodwin, R. D., Kubzansky, L., Lydiard, R. B., Massie, M. J., Katon, W., Laden, S. K., et al. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.12.006 · Cited by 668
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Browning, K. N., & Travagli, R. A. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130055 · Cited by 541
“…LC (202,289,340,342) that not only increases colonic transit but also increases arousal and anxiety-like behaviors which may be of importance in the pathophysiology of functional bowel disorders such as irritable bowel syndrome (IBS) associated with comorbid anxiety and depression (335,461,505).”
Early weaning stress impairs development of mucosal barrier function in the porcine intestine
Smith, F., Clark, J. E., Overman, B. L., Tozel, C. C., Huang, J. H., Rivier, J. E. F., Blisklager, A. T., & Moeser, A. J. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00081.2009 · Cited by 500
Maternal separation as a model of brain-gut axis dysfunction
O’Mahony, S. M., Hyland, N. P., Dinan, T. G., & Cryan, J. F. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2010-9 · Cited by 415
Stress and the Microbiota–Gut–Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome
Moloney, R. D., Johnson, A. C., O'Mahony, S. M., Dinan, T. G., Greenwood‐Van Meerveld, B., & Cryan, J. F. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12490 · Cited by 386
Fundamentals of Neurogastroenterology: Basic Science
Vanner, S. J., Greenwood-Van Meerveld, B., Mawe, G. M., Shea-Donohue, T., Verdu, E. F., Wood, J., & Grundy, D. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.018 · Cited by 369
Jennings, E. M., Okine, B. N., Roche, M., & Finn, D. P. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.06.003 · Cited by 318
Stress signaling pathways activated by weaning mediate intestinal dysfunction in the pig
Moeser, A. J., Klok, C. V., Ryan, K. A., Wooten, J. G., Little, D., Cook, V. L., & Blikslager, A. T. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00197.2006 · Cited by 316
Mayer, E. A., Labus, J. S., Tillisch, K., Cole, S. W., & Baldi, P. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.121 · Cited by 277
CRF induces intestinal epithelial barrier injury via the release of mast cell proteases and TNF-α
Overman, E. L., Rivier, J. E., & Moeser, A. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039935 · Cited by 207
Fu, Y., & Neugebauer, V. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0227-08.2008 · Cited by 184
“An increasing number of studies suggest that CRF1 receptors mediate pronociceptive effects of CRF, whereas CRF2 receptors serve antinociceptive functions (Gue et al., 1997; Million et al., 2003, 2006; Martinez et al., 2004; Tache et al., 2004; Greenwood-Van Meerveld et al., 2005; Nijsen et al., 2005).”
BackgroundBrain and gut CRF signaling: biological actions and role in the gastrointestinal tract
Tache, Y., Larauche, M., Yuan, P.-Q., & Million, M. (2018) · Current Molecular Pharmacology · doi:10.2174/1874467210666170224095741 · Cited by 147
“Both experimental and clinical studies in healthy subjects highlight that the activation of central/peripheral CRF-R1 recapitulates important features occurring in IBS patients (anxiogenic/hypervigilance behavior, colonic mast cell activation and serotonin release, stimulation of colonic propulsive motor function, inc…”
BackgroundInfluentialSelf-citationGareau, M. G., Jury, J., Yang, P. C., MacQueen, G., & Perdue, M. H. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000190577.62426.45 · Cited by 139
“hypersensitivity in rodent models of IBS (16).”
Braak, B., Klooker, T. K., Wouters, M. M., Welting, O., van der Loos, C. M., Stanisor, O. I., van Diest, S., van den Wijngaard, R. M., & Boeckxstaens, G. E. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.54 · Cited by 93
Øines, E., Murison, R., Mrdalj, J., Grønli, J., & Milde, A. M. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.11.024 · Cited by 66
Yuan, Y., Ali, M. K., Mathewson, K. J., Sharma, K., Faiyaz, M., Tan, W., Parsons, S. P., Zhang, K. K., Milkova, N., Liu, L., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01447 · Cited by 28
High Somatic Symptom Burdens and Functional Gastrointestinal Disorders
Sayuk, G. S., Elwing, J. E., Lustman, P. J., & Clouse, R. E. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.11.024 · Cited by 26
Review: Therapeutic advances in functional gastrointestinal disease: irritable bowel syndrome
Gaman, A., Bucur, M. C., & Kuo, B. (2009) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x08103656 · Cited by 12
“could be mediated through activation of the parasympathetic system [Tache et al. 2004].”
BackgroundMethod
Metadata
- Authors
- Taché, Y., Martinez, V, Wang, L., & Million, M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2004-04
- Volume
- 141
- Issue
- 8
- Pages
- 1321-1330
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1975941894
- Cited by
- 228
- References
- 13
- FWCI
- 14.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.